v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Series 1 Convertible
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2024 $ 35 $ 412,077 $ (244,980) $ 2 $ 167,134
Balance (in Shares) at Dec. 31, 2024 7,991 35,044,772        
Issuance of common stock upon conversion of Series 1 Preferred Stock $ 2 (2)
Issuance of common stock upon conversion of Series 1 Preferred Stock (in Shares) (2,376) 2,376,244        
Issuance of common stock upon exercise of pre-funded warrants $ 1 1
Issuance of common stock upon exercise of pre-funded warrants (in Shares)   625,100        
Issuance of common stock from December 2024 Public Offering, net of offering costs of $214 $ 1 2,527 2,528
Issuance of common stock from December 2024 Public Offering, net of offering costs of $214 (in Shares)   438,738        
Issuance of common stock upon settlement of restricted stock units (185) (185)
Issuance of common stock upon settlement of restricted stock units (in Shares)   92,959        
Stock-based compensation - restricted stock units 121 121
Stock-based compensation - stock options 712 712
Unrealized gain (loss) on marketable debt securities 87 87
Net income (loss) (11,914) (11,914)
Balance at Mar. 31, 2025 $ 39 415,250 (256,894) 89 158,484
Balance (in Shares) at Mar. 31, 2025 5,615 38,577,813        
Balance at Dec. 31, 2024 $ 35 412,077 (244,980) 2 167,134
Balance (in Shares) at Dec. 31, 2024 7,991 35,044,772        
Net income (loss)           (26,874)
Balance at Jun. 30, 2025 $ 39 416,161 (271,854) 77 144,423
Balance (in Shares) at Jun. 30, 2025 5,615 38,581,863        
Balance at Mar. 31, 2025 $ 39 415,250 (256,894) 89 158,484
Balance (in Shares) at Mar. 31, 2025 5,615 38,577,813        
Issuance of common stock upon exercise of stock options 8 8
Issuance of common stock upon exercise of stock options (in Shares) 2,842        
Issuance of common stock upon settlement of restricted stock units
Issuance of common stock upon settlement of restricted stock units (in Shares) 1,208        
Stock-based compensation - restricted stock units 167 167
Stock-based compensation - stock options 736 736
Unrealized gain (loss) on marketable debt securities (12) (12)
Net income (loss) (14,960) (14,960)
Balance at Jun. 30, 2025 $ 39 416,161 (271,854) 77 144,423
Balance (in Shares) at Jun. 30, 2025 5,615 38,581,863        
Balance at Dec. 31, 2025 $ 54 498,687 (302,419) 90 196,412
Balance (in Shares) at Dec. 31, 2025 5,615 53,587,260        
Issuance of common stock upon conversion of Series 1 Preferred Stock $ 1 (1)
Issuance of common stock upon conversion of Series 1 Preferred Stock (in Shares) (971) 971,204        
Issuance of common stock upon exercise of common warrants 1,942 1,942
Issuance of common stock upon exercise of common warrants (in Shares)   370,000        
Issuance of common stock upon settlement of restricted stock units (272) (272)
Issuance of common stock upon settlement of restricted stock units (in Shares)   127,118        
Stock-based compensation - restricted stock units 317 317
Stock-based compensation - stock options 1,045 1,045
Unrealized gain (loss) on marketable debt securities (454) (454)
Net income (loss) (17,782) (17,782)
Balance at Mar. 31, 2026 $ 55 501,718 (320,201) (364) 181,208
Balance (in Shares) at Mar. 31, 2026 4,644 55,055,582        
Balance at Dec. 31, 2025 $ 54 498,687 (302,419) 90 196,412
Balance (in Shares) at Dec. 31, 2025 5,615 53,587,260        
Net income (loss)           (39,450)
Balance at Jun. 30, 2026 $ 59 503,484 (341,869) (363) 161,311
Balance (in Shares) at Jun. 30, 2026 872 59,083,935        
Balance at Mar. 31, 2026 $ 55 501,718 (320,201) (364) 181,208
Balance (in Shares) at Mar. 31, 2026 4,644 55,055,582        
Issuance of common stock upon exercise of stock options 412 412
Issuance of common stock upon exercise of stock options (in Shares) 215,687        
Issuance of common stock upon conversion of Series 1 Preferred Stock $ 4 (4)
Issuance of common stock upon conversion of Series 1 Preferred Stock (in Shares) (3,772) 3,773,586        
Issuance of common stock upon settlement of restricted stock units (26) (26)
Issuance of common stock upon settlement of restricted stock units (in Shares) 39,080        
Stock-based compensation - restricted stock units 294 294
Stock-based compensation - stock options 1,090 1,090
Unrealized gain (loss) on marketable debt securities 1 1
Net income (loss) (21,668) (21,668)
Balance at Jun. 30, 2026 $ 59 $ 503,484 $ (341,869) $ (363) $ 161,311
Balance (in Shares) at Jun. 30, 2026 872 59,083,935